UiPath (NYSE:PATH – Get Free Report) had its price target cut by stock analysts at BMO Capital Markets from $18.00 to $15.00 in a note issued to investors on Thursday, Briefing.com reports. The firm presently has a “market perform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 14.93% from the company’s current price.
A number of other analysts also recently weighed in on the stock. Royal Bank Of Canada reissued an “outperform” rating on shares of UiPath in a research report on Wednesday. Barclays increased their price objective on shares of UiPath from $14.00 to $17.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. HC Wainwright reissued a “buy” rating on shares of UiPath in a research note on Friday, September 4th. TD Cowen restated a “hold” rating and issued a $16.00 target price on shares of UiPath in a report on Wednesday. Finally, UBS Group reaffirmed a “buy” rating on shares of UiPath in a research report on Wednesday. Five analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, UiPath currently has a consensus rating of “Hold” and an average price target of $16.19.
Check Out Our Latest Report on PATH
UiPath Stock Down 1.5%
UiPath (NYSE:PATH – Get Free Report) last announced its earnings results on Thursday, September 3rd. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. UiPath had a return on equity of 9.70% and a net margin of 21.03%.The business had revenue of $410.26 million during the quarter, compared to analyst estimates of $397.77 million. During the same period last year, the company earned $0.15 EPS. UiPath’s revenue for the quarter was up 13.3% compared to the same quarter last year. As a group, equities analysts anticipate that UiPath will post 0.47 earnings per share for the current fiscal year.
Insider Transactions at UiPath
In other news, insider Raghavendra Malpani sold 40,464 shares of UiPath stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $14.00, for a total value of $566,496.00. Following the completion of the sale, the insider owned 1,582,213 shares in the company, valued at $22,150,982. The trade was a 2.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Ashim Gupta sold 117,339 shares of the business’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $13.85, for a total transaction of $1,625,145.15. Following the transaction, the chief operating officer owned 2,037,377 shares in the company, valued at $28,217,671.45. The trade was a 5.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,560,150 shares of company stock valued at $24,727,357 in the last quarter. 22.44% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On UiPath
Several hedge funds and other institutional investors have recently bought and sold shares of PATH. Pasadena Private Wealth LLC boosted its holdings in UiPath by 9.0% in the first quarter. Pasadena Private Wealth LLC now owns 12,750 shares of the company’s stock worth $142,000 after acquiring an additional 1,050 shares in the last quarter. Allworth Financial LP increased its holdings in shares of UiPath by 5.2% during the second quarter. Allworth Financial LP now owns 23,537 shares of the company’s stock valued at $256,000 after acquiring an additional 1,160 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of UiPath by 36.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 4,968 shares of the company’s stock worth $81,000 after purchasing an additional 1,329 shares during the last quarter. Corient Private Wealth LLC raised its position in shares of UiPath by 5.6% in the 4th quarter. Corient Private Wealth LLC now owns 27,283 shares of the company’s stock worth $447,000 after purchasing an additional 1,455 shares during the last quarter. Finally, Wedbush Securities Inc. boosted its stake in UiPath by 14.0% in the 2nd quarter. Wedbush Securities Inc. now owns 11,920 shares of the company’s stock worth $130,000 after purchasing an additional 1,465 shares in the last quarter. 62.50% of the stock is owned by institutional investors.
More UiPath News
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: UiPath introduced new AI-powered capabilities for Test Cloud, including autonomous software testing designed to help enterprises expand testing at scale. The launch could strengthen UiPath’s position in enterprise automation and create additional upselling opportunities. UiPath Expands Test Cloud With Autonomous Testing Features
- Positive Sentiment: The company launched UiPath Cartographer, a product that creates a governed, continuously updated view of how business processes operate. Management is positioning Cartographer and other platform enhancements as a bridge between traditional process automation, agentic AI and orchestration, potentially expanding UiPath’s addressable market. UiPath Launches UiPath Cartographer
- Neutral Sentiment: Analyst opinions remained mixed. Needham reiterated a Buy rating with a $22 target, while TD Cowen maintained Hold with a $16 target. The targets imply meaningful potential upside, but the differing ratings show that investors remain divided over UiPath’s execution and growth outlook.
- Neutral Sentiment: UiPath also highlighted partner recognition and broader platform upgrades at FUSION 2026. These announcements support ecosystem development, but they did not include new financial goals or guidance that would immediately change earnings expectations. UiPath Honors 2026 Partner Award Winners
- Negative Sentiment: RBC Capital lowered its price target from $17 to $15 and UBS cut its target from $19 to $15, with both firms retaining cautious ratings. The reductions indicate that analysts want evidence of renewed growth momentum before becoming more bullish. RBC Lowers UiPath Price Target
- Negative Sentiment: RBC described UiPath’s transition toward business orchestration and automation as a “show-me story,” while Truist also trimmed its target after the investor event did not provide new objectives. Investors appear focused on whether the new AI products can translate into accelerating revenue and cash flow rather than announcements alone. Truist Trims UiPath Target
About UiPath
UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.
The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.
Read More
- Five stocks we like better than UiPath
- DraftKings Falls 7.6%: Is Kalshi’s NFL Lead Really That Big?
- Gaming Your Portfolio: Should You Add Take-Two Ahead of GTA 6’s November Launch?
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
